Anebulo Pharmaceuticals
Clinical trials sponsored by Anebulo Pharmaceuticals, explained in plain language.
Clinical-stage biopharma developing treatments for acute cannabinoid intoxication.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New study tracks THC in kids after cannabis overdose Results expected Dec 2026 (estimated)